{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:06:07Z","timestamp":1775160367795,"version":"3.50.1"},"reference-count":53,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,1]]},"DOI":"10.1210\/jc.2008-2671","type":"journal-article","created":{"date-parts":[[2009,4,14]],"date-time":"2009-04-14T20:39:10Z","timestamp":1239741550000},"page":"2471-2477","source":"Crossref","is-referenced-by-count":56,"title":["Growth Hormone Deficiency Is Associated with Decreased Quality of Life in Patients with Prior Acromegaly"],"prefix":"10.1210","volume":"94","author":[{"given":"Tamara","family":"Wexler","sequence":"first","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Gunnell","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehra","family":"Omer","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Kuhlthau","sequence":"additional","affiliation":[{"name":"Center for Pediatric and Adolescent Health Policy (K.K.), Department of Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Beauregard","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenda","family":"Graham","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Utz","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Biller","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Nachtigall","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Loeffler","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology (J.L.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Swearingen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery (B.S.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Klibanski","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K.","family":"Miller","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (T.W., L.G., Z.O., C.B., G.G., A.L.U., B.B., L.N., A.K., K.K.M.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113441304700_R1","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/jc.2002-021792","article-title":"Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module.","volume":"88","author":"Blum","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2265.2002.01608.x","article-title":"The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults.","volume":"57","author":"Gilchrist","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113441304700_R3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1994.tb02452.x","article-title":"Decreased psychological well-being in adult patients with growth hormone deficiency.","volume":"40","author":"Rosen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113441304700_R4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2265.1998.00634.x","article-title":"One-year follow-up of quality of life in adults with untreated growth hormone deficiency.","volume":"49","author":"Badia","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113441304700_R5","first-page":"73","article-title":"Quality of life of adults with growth hormone deficiency: a controlled study","author":"Bjork","year":"1989","journal-title":"Acta Paediatr Scand Suppl 356:55\u201359; discussion 60,"},{"key":"key\n\t\t\t\t2019041113441304700_R6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ecl.2006.11.011","article-title":"Quality of life in growth hormone deficiency and acromegaly.","volume":"36","author":"Webb","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key\n\t\t\t\t2019041113441304700_R7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/er.2004-0022","article-title":"The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.","volume":"27","author":"Woodhouse","year":"2006","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113441304700_R8","first-page":"73","article-title":"Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency","author":"McGauley","year":"1989","journal-title":"Acta Paediatr Scand Suppl 356:70\u201372; discussion"},{"key":"key\n\t\t\t\t2019041113441304700_R9","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2004-1565","article-title":"Quality of life (QOL) in patients with acromegaly is severely impaired. Use of a novel measure of QOL: acromegaly quality of life questionnaire.","volume":"90","author":"Rowles","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000095532","article-title":"Quality of life in acromegaly.","volume":"83","author":"Webb","year":"2006","journal-title":"Neuroendocrinology"},{"key":"key\n\t\t\t\t2019041113441304700_R11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2265.2005.02307.x","article-title":"Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).","volume":"63","author":"Trepp","year":"2005","journal-title":"Clin Endocrinol (Oxf) [Erratum (2005) 63:238]"},{"key":"key\n\t\t\t\t2019041113441304700_R12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1022145116901","article-title":"Self image and quality of life in acromegaly.","volume":"5","author":"Pantanetti","year":"2002","journal-title":"Pituitary"},{"key":"key\n\t\t\t\t2019041113441304700_R13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2007.02891.x","article-title":"Treatment of acromegaly improves quality of life, measured by AcroQol.","volume":"67","author":"Paisley","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113441304700_R14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/EJE-07-0697","article-title":"Impaired quality of life of patients with acromegaly: control of GH\/IGF-I excess improves psychological subscale appearance.","volume":"158","author":"Matta","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113441304700_R15","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1210\/jc.2004-0669","article-title":"Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess.","volume":"89","author":"Biermasz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R16","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/jc.2004-2297","article-title":"Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life.","volume":"90","author":"Biermasz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","article-title":"Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas.","volume":"69","author":"Klaauw","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113441304700_R18","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1210\/jc.2006-0676","article-title":"Quality of life in treated patients with acromegaly.","volume":"91","author":"Kauppinen-Ma\u0308kelin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-007-0078-y","article-title":"Radiotherapy and radiosurgery in acromegaly.","volume":"12","author":"Castinetti","year":"2009","journal-title":"Pituitary"},{"key":"key\n\t\t\t\t2019041113441304700_R20","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1210\/jc.2006-2599","article-title":"Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal.","volume":"92","author":"Darzy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"key\n\t\t\t\t2019041113441304700_R21","first-page":"1","article-title":"Radiation-induced growth hormone deficiency","volume":"59","author":"Darzy","year":"2003","journal-title":"Horm Res"},{"issue":"Suppl A","key":"key\n\t\t\t\t2019041113441304700_R22","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.ghir.2004.03.038","article-title":"Endocrine consequences of brain irradiation","volume":"14","author":"Toogood","year":"2004","journal-title":"Growth Horm IGF Res"},{"key":"key\n\t\t\t\t2019041113441304700_R23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","article-title":"Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?","volume":"87","author":"Hartman","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R24","first-page":"1615","article-title":"Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.","volume":"83","author":"Aimaretti","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1530\/eje.0.1340352","article-title":"New approach to the diagnosis of growth hormone deficiency in adults.","volume":"134","author":"Ghigo","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113441304700_R26","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","article-title":"Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.","volume":"87","author":"Biller","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","article-title":"The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency.","volume":"8","author":"McKenna","year":"1999","journal-title":"Qual Life Res"},{"key":"key\n\t\t\t\t2019041113441304700_R28","first-page":"63","article-title":"Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency.","volume":"2","author":"Holmes","year":"1995","journal-title":"Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R29","first-page":"268","article-title":"A symptom questionnaire.","volume":"48","author":"Kellner","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019041113441304700_R30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1192\/bjp.188.4.346","article-title":"Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study.","volume":"188","author":"Perahia","year":"2006","journal-title":"Br J Psychiatry"},{"key":"key\n\t\t\t\t2019041113441304700_R31","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1001\/archinte.166.17.1878","article-title":"Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation.","volume":"166","author":"Lavie","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113441304700_R32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1176\/appi.psy.47.4.348","article-title":"Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine.","volume":"47","author":"Denninger","year":"2006","journal-title":"Psychosomatics"},{"key":"key\n\t\t\t\t2019041113441304700_R33","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1176\/ajp.150.8.1158","article-title":"Anger attacks in unipolar depression. Part 1: Clinical correlates and response to fluoxetine treatment.","volume":"150","author":"Fava","year":"1993","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019041113441304700_R34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/070674378302800208","article-title":"Italian validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ).","volume":"28","author":"Fava","year":"1983","journal-title":"Can J Psychiatry"},{"key":"key\n\t\t\t\t2019041113441304700_R35","article-title":"SF-36 Health survey manual and interpretation guide.","author":"Ware","year":"1993"},{"key":"key\n\t\t\t\t2019041113441304700_R36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"key":"key\n\t\t\t\t2019041113441304700_R37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1460067","article-title":"Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing\u2019s disease.","volume":"146","author":"Feldt-Rasmussen","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113441304700_R38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.02214","article-title":"Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.","volume":"155","author":"Webb","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113441304700_R39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/026988110201600304","article-title":"Fluoxetine treatment of depressed patients with comorbid anxiety disorders.","volume":"16","author":"Sonawalla","year":"2002","journal-title":"J Psychopharmacol"},{"key":"key\n\t\t\t\t2019041113441304700_R40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.2007.03169.x","article-title":"Previous radiotherapy negatively influences quality of life during four years of follow-up in patients cured from acromegaly.","volume":"69","author":"Klaauw","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113441304700_R41","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1210\/jc.2003-032213","article-title":"Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency.","volume":"89","author":"Bonert","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113441304700_R43","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jc.2004-1450","article-title":"Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests.","volume":"90","author":"Qu","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R44","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2005-0439","article-title":"Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood.","volume":"90","author":"Attanasio","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R45","first-page":"107","article-title":"The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.","volume":"83","author":"Cuneo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1995.tb01909.x","article-title":"Factors influencing the desire for long-term growth hormone replacement in adults.","volume":"43","author":"Holmes","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 4","key":"key\n\t\t\t\t2019041113441304700_R47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000181584","article-title":"Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency","volume":"33","author":"McGauley","year":"1990","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041113441304700_R48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2265.2001.01275.x","article-title":"Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.","volume":"54","author":"Ahmad","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113441304700_R49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1477-7525-3-63","article-title":"Differential effect sizes of growth hormone replacement on quality of life, well-being and health status in growth hormone deficient patients: a meta-analysis","volume":"3","author":"Deijen","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"key\n\t\t\t\t2019041113441304700_R50","first-page":"46","article-title":"Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency.","volume":"64","author":"Ko\u0142towska-Haggstrom","year":"2005","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041113441304700_R51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1530\/eje.1.02209","article-title":"Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database.","volume":"155","author":"Maiter","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113441304700_R52","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/jc.2003-030134","article-title":"Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H).","volume":"89","author":"Rosilio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113441304700_R53","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2265.1998.00462.x","article-title":"Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency.","volume":"48","author":"Wiren","year":"1998","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/7\/2471\/9065678\/jcem2471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T08:56:42Z","timestamp":1558256202000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/7\/2471\/2596999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,1]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-2671","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,1]]}}}